ArticleHernia : the journal of hernias and abdominal wall surgery2026
Electromyographic and tomographic muscle changes after botulinum toxin administration through either 3 or 8 injection points in patients with large midline ventral hernias: a superiority study.
Article in Hernia : the journal of hernias and abdominal wall surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIn this superiority study, the primary endpoint was to evaluate whether muscle changes in amplitude, thickness and length are superior when administering botulinum toxin to external and internal oblique muscles using small volumes through 8 injection points compared to large volumes through 3 injection points in patients with large midline ventral hernias. A secondary endpoint was to assess new symptoms developed after injections.
methodsBetween March 2023 and July 2025, 31 patients with large midline ventral hernias underwent pre-habilitation with botulinum toxin injected to the external and internal oblique muscles. In each patient, a dose of 100 units of botulinum toxin was administered on the right side through 3 injection points using a volume of 48 cc, and the same dose was administered on the left side through 8 injection points using a volume of 16 cc. Muscle amplitude, thickness and length on each side were compared before and 4 weeks after injection using the Wilcoxon signed-ranked test for matched pairs. The changes seen between sides were compared using the Wilcoxon signed-ranked test and adjusted with the Benjamini-Hochberg false discovery rate method.
resultsMuscle amplitude decreased 52% on the 8-injection point side (from 275 µV to 121 µV; p = 0.003) and 50% on the 3-injection point side (from 259 µV to 129 µV vs.; p = 0.01) (95% CI between sides [-0.14, 0.27]; p = 0.14). Muscle thickness was reduced by 31% on the 8-injection point side (from 28 mm to 18 mm; p = 0.002) and 28% on the 3-injection point side (from 28 mm to 18 mm; p = 0.004) (95% CI between sides [-0.06, 0.09]; p = 0.89). Muscle length increased 26% on the 8-injection point side (from 113 mm to 154 mm; p = 0.001) and 15% on the 3-injection point side (from 124 mm to 139 mm; p = 0.003) (95% CI between sides [-0.13, 0.04]; p = 0.61). No new symptoms were recorded after botulinum toxin injections.
conclusionIn a group of patients with large midline ventral hernias, the degree of change in muscle amplitude, thickness and length was not superior when botulinum toxin was administered using small volumes through 8 injection points compared to large volumes through 3 injection points.
Indexed as
Identifiers
42257791What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.